Treatment of recalcitrant ulcers in pyoderma gangrenosum with mycophenolate mofetil and autologous keratinocyte transplantation on a hyaluronic acid matrix
- 1 May 2000
- journal article
- case report
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 14 (3), 187-190
- https://doi.org/10.1046/j.1468-3083.2000.00019.x
Abstract
Pyoderma gangrenosum sometimes takes a recalcitrant course that is unresponsive to standard immunosuppression with corticosteroids and/or cyclosporin A. In these cases improvement of painful ulcerations is a therapeutic challenge. We report a 17‐year‐old boy with severe pyoderma gangrenosum treated successfully with mycophenolate mofetil and autologous keratinocyte transplantation using an esterified hyluronic acid delivery system.Keywords
This publication has 19 references indexed in Scilit:
- Clinical Pharmacokinetics of Mycophenolate MofetilClinical Pharmacokinetics, 1998
- Pyoderma gangrenosum: a report of 44 cases with follow-upBritish Journal of Dermatology, 1997
- Treatment of pyoderma gangrenosumJournal of the American Academy of Dermatology, 1996
- Pyoderma gangrenosum: Classification and managementJournal of the American Academy of Dermatology, 1996
- A controlled study of the activity of hyaluronic acid in the treatment of venous leg ulcersJournal of Dermatological Treatment, 1996
- Pyoderma Gangrenosum in Infants and ChildrenPediatric Dermatology, 1994
- Hyaluronic AcidDrugs, 1994
- Treatment of pyoderma gangrenosum with cyclosporine: Results in seven patientsJournal of the American Academy of Dermatology, 1991
- Pyoderma gangrenosum treated with cyclosporin ABritish Journal of Dermatology, 1985
- Healing of hyaluronic acid-enriched wounds: Histological observationsJournal of Surgical Research, 1983